Does fluoxetine (Prozak) block mitochondrial permeability transition by blocking VDAC as part of permeability transition pores?
Thinnes
Friedrich P
FP
D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D001402:B-Lymphocytes / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D005473:Fluoxetine / Q000494:pharmacology*; D006801:Humans; D007425:Intracellular Membranes / Q000187:drug effects; D008051:Lipid Bilayers; D008928:Mitochondria / Q000187:drug effects*; D010539:Permeability; D018272:Porins / Q000187:drug effects* / Q000378:metabolism; D050994:Voltage-Dependent Anion Channels
D018687:Antidepressive Agents, Second-Generation; D008051:Lipid Bilayers; D018272:Porins; D050994:Voltage-Dependent Anion Channels; D005473:Fluoxetine